您当前的位置：
首页 >
文章列表页 >
Clinical diagnosis value of 18F-fibroblast-activation protein inhibitor PET/CT in malignant tumors with low 18F-fluorodeoxyglucose uptake
Medical Journal of Chinese People′s Liberation Army   Vol. 50, Issue 2, Pages: 154-161(2025)
Clinical Research | 更新时间：2025-03-10
|

    • Clinical diagnosis value of 18F-fibroblast-activation protein inhibitor PET/CT in malignant tumors with low 18F-fluorodeoxyglucose uptake

    • “According to the latest research, 18F-FAPI PET/CT has significant advantages in diagnosing malignant tumors with low 18F-FDG uptake, providing a new method for clinical diagnosis.”

    • DOI：10.11855/j.issn.0577-7402.1631.2024.0708    

      CLC： R730.44

    • Received：09 December 2023，

      Accepted：2024-05-11，

      Published Online：08 July 2024，

      Published：28 February 2025

    移动端阅览

  • Liang Zhi-Ying,Lin Pei-Ying,Zhang Ru-Sen,et al.Clinical diagnosis value of 18F-fibroblast-activation protein inhibitor PET/CT in malignant tumors with low 18F-fluorodeoxyglucose uptake[J].Medical Journal of Chinese People′s Liberation Army,2025,50(02):154-161. DOI： 10.11855/j.issn.0577-7402.1631.2024.0708.

  •  
  •  

0

Views

0

下载量

0

CSCD

0

CNKI被引量

>
Alert me when the article has been cited
提交
Outline
No Sections

Related Articles

EFFECT OF MICROWAVE COAGULATING AND HAEMSOTATIC HEPATECTOMY ON THE PROGNOSIS OF LIVER CANCER

Related Author

张文智
冯玉泉
王悦华

Related Institution

北京解放军总医院
0